Clinical TrialsTakeda’s Zasocitinib Shows Phase 3 Efficacy in Scalp, Nail, Palmoplantar ... Takeda’s Zasocitinib Shows Phase 3 Efficacy in Scalp, Nail, Palmoplantar ... Read Post »
Clinical TrialsVeradermics Reports Positive Age-Based Phase 2/3 Data for VDPHL01 in Male H... Veradermics Reports Positive Age-Based Phase 2/3 Data for VDPHL01 in Male H... Read Post »
Clinical TrialsEvaxion Reports Three-Year EVX-01 Phase 2 Melanoma Results at ESMO 2026 Evaxion Reports Three-Year EVX-01 Phase 2 Melanoma Results at ESMO 2026 Read Post »
Clinical TrialsKalaris Reports Positive Phase 1a Results for TH103 in Neovascular AMD Kalaris Reports Positive Phase 1a Results for TH103 in Neovascular AMD Read Post »
Clinical TrialsGSK Ends Camlipixant Development After Mixed CALM Phase III Results GSK Ends Camlipixant Development After Mixed CALM Phase III Results Read Post »
New Drug ApprovalEuropean Commission Approves JASCAYD® (Nerandomilast) for Adults with IPF ... European Commission Approves JASCAYD® (Nerandomilast) for Adults with IPF ... Read Post »
Clinical TrialsFirst KRAS Vaccine Shows Promise for Pancreatic Cancer Prevention First KRAS Vaccine Shows Promise for Pancreatic Cancer Prevention Read Post »
Clinical TrialsModerna Advances mRNA-4200 into Phase 1 Study for Advanced Solid Tumors Moderna Advances mRNA-4200 into Phase 1 Study for Advanced Solid Tumors Read Post »
Clinical TrialsMeiji Seika Highlights Phase III Nacubactam Trial Results Meiji Seika Highlights Phase III Nacubactam Trial Results Read Post »
Clinical TrialsBoehringer Ingelheim Advances First-in-Class Triple Agonist BI 3034701 Into... Boehringer Ingelheim Advances First-in-Class Triple Agonist BI 3034701 Into... Read Post »
New Drug ApprovalNICE Recommends Finerenone for Chronic Heart Failure with Preserved or Mild... NICE Recommends Finerenone for Chronic Heart Failure with Preserved or Mild... Read Post »
Clinical TrialsAelis Farma Phase 2b Trial of AEF0217 Clears First IDMC Safety Review in Do... Aelis Farma Phase 2b Trial of AEF0217 Clears First IDMC Safety Review in Do... Read Post »
Clinical TrialsKairos Reports Favorable Safety Data for ENV-105 Plus Osimertinib in EGFR-M... Kairos Reports Favorable Safety Data for ENV-105 Plus Osimertinib in EGFR-M... Read Post »
New Drug ApprovalFDA Approves Merck’s LIPFENDRA as First Oral PCSK9 Inhibitor FDA Approves Merck’s LIPFENDRA as First Oral PCSK9 Inhibitor Read Post »
Clinical TrialsInsmed Report Positive 12-Month Data from the OLE Study of Treprostinil Pal... Insmed Report Positive 12-Month Data from the OLE Study of Treprostinil Pal... Read Post »
Drugs Safety AlertMHRA Warns of Rare Botulism Risk with Botulinum Toxin Products MHRA Warns of Rare Botulism Risk with Botulinum Toxin Products Read Post »
Clinical TrialsChimeric Therapeutics Reports New Tumor Shrinkage Data with CHM CDH17 CAR-T... Chimeric Therapeutics Reports New Tumor Shrinkage Data with CHM CDH17 CAR-T... Read Post »
New Drug ApprovalEuropean Commission Approves Wegovy® Pill as First Oral GLP-1 Therapy for ... European Commission Approves Wegovy® Pill as First Oral GLP-1 Therapy for ... Read Post »
Clinical TrialsORIC Initiates Global Phase 3 Himalayas-1 Trial of Rinzimetostat Plus Darol... ORIC Initiates Global Phase 3 Himalayas-1 Trial of Rinzimetostat Plus Darol... Read Post »
Clinical TrialsBPGbio’s BPM31510 Shows Encouraging Survival Signal in Phase 2 Glioblasto... BPGbio’s BPM31510 Shows Encouraging Survival Signal in Phase 2 Glioblasto... Read Post »
Clinical TrialsAllogene’s ALLO-316 Shows 31% Response Rate in CD70-High Advanced Kidney ... Allogene’s ALLO-316 Shows 31% Response Rate in CD70-High Advanced Kidney ... Read Post »
Clinical TrialsBiogen and Eisai Present LEADER Study Results for LEQEMBI at AAIC 2026 Biogen and Eisai Present LEADER Study Results for LEQEMBI at AAIC 2026 Read Post »
Clinical TrialsKelun-Biotech Reports Positive Phase III OptiTROP-Lung06 Results in NSCLC Kelun-Biotech Reports Positive Phase III OptiTROP-Lung06 Results in NSCLC Read Post »
Clinical TrialsJAMA Publishes Phase 2 Ceperognastat Trial Results in Early Alzheimer’... JAMA Publishes Phase 2 Ceperognastat Trial Results in Early Alzheimer’... Read Post »
New Drug ApprovalFDA Grants Full Approval to Retevmo for RET Fusion-Positive Solid Tumors Ac... FDA Grants Full Approval to Retevmo for RET Fusion-Positive Solid Tumors Ac... Read Post »
New Drug ApprovalFDA Approves REVTORPYK for PIK3CA Wild-Type HR+/HER2- Advanced Breast Cance... FDA Approves REVTORPYK for PIK3CA Wild-Type HR+/HER2- Advanced Breast Cance... Read Post »
Clinical TrialsMediPharm Reports Positive Phase 2 LiBBY Results for Oral Cannabinoid Thera... MediPharm Reports Positive Phase 2 LiBBY Results for Oral Cannabinoid Thera... Read Post »
Clinical TrialsBiogen Advances Diranersen to Phase 3 After Positive CELIA Data Biogen Advances Diranersen to Phase 3 After Positive CELIA Data Read Post »
Clinical TrialsImmutep Reports 30.9-Month Overall Survival in Phase I INSIGHT-003 Trial of... Immutep Reports 30.9-Month Overall Survival in Phase I INSIGHT-003 Trial of... Read Post »
Clinical TrialsHemab Reports Durable Phase 2 Results for Sutacimig in Glanzmann Thrombasth... Hemab Reports Durable Phase 2 Results for Sutacimig in Glanzmann Thrombasth... Read Post »
Clinical TrialsDefinium Study Shows High Treatment Discontinuation in Generalized Anxiety ... Definium Study Shows High Treatment Discontinuation in Generalized Anxiety ... Read Post »
Clinical TrialsEisai Presents Findings Showing Etalanetug Reduced Alzheimer’s Tau Ta... Eisai Presents Findings Showing Etalanetug Reduced Alzheimer’s Tau Ta... Read Post »
Clinical TrialsOncolytics Advances Pelareorep Toward Registration in Metastatic Colorectal... Oncolytics Advances Pelareorep Toward Registration in Metastatic Colorectal... Read Post »
New Drug ApprovalFDA Approves Weekly LEQEMBI IQLIK Autoinjector for At-Home Initiation of Ea... FDA Approves Weekly LEQEMBI IQLIK Autoinjector for At-Home Initiation of Ea... Read Post »
Clinical TrialsANI Reports Positive Results for ILUVIEN in Chronic Posterior Uveitis ANI Reports Positive Results for ILUVIEN in Chronic Posterior Uveitis Read Post »
Clinical TrialsCadrenal Reports Phase 2 CAD-1005 Data Showing Reduced Thrombotic Events in... Cadrenal Reports Phase 2 CAD-1005 Data Showing Reduced Thrombotic Events in... Read Post »
Clinical TrialsHemab Reports Positive HMB-002 Results, Introduces HMB-003 at ISTH 2026 Hemab Reports Positive HMB-002 Results, Introduces HMB-003 at ISTH 2026 Read Post »
Clinical TrialsAlixorexton Shows Sustained Wakefulness and Daytime Sleepiness Benefits for... Alixorexton Shows Sustained Wakefulness and Daytime Sleepiness Benefits for... Read Post »
Clinical TrialsQ32 Bio Reports Positive Phase 2 Results for Bempikibart in Alopecia Areata Q32 Bio Reports Positive Phase 2 Results for Bempikibart in Alopecia Areata Read Post »
Clinical TrialsGSK’s Jemperli Phase II Trial Shows Durable Complete Responses in dMMR Re... GSK’s Jemperli Phase II Trial Shows Durable Complete Responses in dMMR Re... Read Post »
Clinical TrialsLifestyle Intervention Improves Cognitive Function in Older Adults at Risk ... Lifestyle Intervention Improves Cognitive Function in Older Adults at Risk ... Read Post »
Clinical TrialsAAIC 2026: Subcutaneous LEQEMBI Matches IV Therapy in Early Alzheimer’... AAIC 2026: Subcutaneous LEQEMBI Matches IV Therapy in Early Alzheimer’... Read Post »
Clinical TrialsIN8bio Publishes Phase 1 INB-200 Glioblastoma Data in JCO Showing Survival ... IN8bio Publishes Phase 1 INB-200 Glioblastoma Data in JCO Showing Survival ... Read Post »
Clinical TrialsNovo Nordisk Reports Positive Results for Denecimig and Concizumab Novo Nordisk Reports Positive Results for Denecimig and Concizumab Read Post »
Clinical TrialsAB Science Discontinues Three Masitinib Trials to Prioritize ALS Phase III ... AB Science Discontinues Three Masitinib Trials to Prioritize ALS Phase III ... Read Post »
Drugs Safety AlertJAMA Explores Evidence Behind HHS Proposed Testosterone Label Revisions JAMA Explores Evidence Behind HHS Proposed Testosterone Label Revisions Read Post »
ResearchNew Study Challenges Autism Concerns Over Acetaminophen Use During Pregnanc... New Study Challenges Autism Concerns Over Acetaminophen Use During Pregnanc... Read Post »
New Drug ApprovalFDA Approves Merck’s Keytruda Plus Pfizer-Astellas’ Padcev for ... FDA Approves Merck’s Keytruda Plus Pfizer-Astellas’ Padcev for ... Read Post »
Clinical TrialsBausch + Lomb Discontinues BL1107 Eye Drops Following Phase 2 Glaucoma Fail... Bausch + Lomb Discontinues BL1107 Eye Drops Following Phase 2 Glaucoma Fail... Read Post »
Drugs Safety AlertEMA PRAC Adds Meningioma Warning for Desogestrel Contraceptives EMA PRAC Adds Meningioma Warning for Desogestrel Contraceptives Read Post »
